You are here

oncology

AstraZeneca appoints WPP as one of its primary oncology network partners

Medical Marketing and Media

Wed, 07/10/24 - 11:15 am

AI Enables Individualized Cancer Vaccines

BioSpace

Mon, 06/17/24 - 11:03 am

artificial intelligence

cancer vaccines

Pfizer expects 8 blockbuster cancer drugs to come from each of 4 focus areas: exec

Fierce Pharma

Thu, 06/13/24 - 11:14 pm

With 2 planned launches, Boehringer Ingelheim looks to make a name for itself in oncology

Fierce Pharma

Mon, 06/10/24 - 06:07 pm

Boehringer Ingelheim

A ‘widening gap’ in access to new cancer meds drives efforts from City of Hope and Bristol Myers

Pharma Voice

Thu, 06/6/24 - 11:36 am

Bristol Myers Squibb

Merck KGaA taps AI-focused biotech for new ADC pact worth $376M

Fierce Biotech

Tue, 06/4/24 - 11:33 am

Biolojic Design

antibody-drug conjugates

Clinical-stage cancer biotech Actuate latest to eye summer IPO

Fierce Biotech

Tue, 05/28/24 - 10:53 am

Actuate Therapeutics

Where competition is heating up in pharma

Pharma Voice

Fri, 05/24/24 - 11:06 am

ulcerative colitis

Moderna Therapeutics

Boehringer outlines up to $33.6m for cancer asset from OSE Therapeutics

Clinical Trials Arena

Thu, 05/23/24 - 09:43 pm

Boehringer Ingelheim

OSE Immunotherapeutics

AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies

Fierce Biotech

Thu, 05/23/24 - 10:47 am

Nona Biosciences

Too old for pediatric trials, too young for adult trials

Clinical Trials Arena

Mon, 05/13/24 - 11:10 am

clinical trials

Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?

BioSpace

Mon, 05/13/24 - 10:50 am

cancer vaccines

The Enhertu effect: Daiichi’s plan to build on the success of its crown jewel

Pharma Voice

Fri, 05/10/24 - 11:12 am

AZ oncology chief says AI can help solve cancer’s ‘ZIP code lottery’ as health disparities persist

Pharma Voice

Wed, 05/8/24 - 11:25 am

artificial intelligence

How mRNA vaccines could be personalized cancer cures

Axios

Tue, 05/7/24 - 10:59 am

personalized medicine

AstraZeneca Invests $140M in Cellectis, Secures 44% Stake in CAR-T Specialist

BioSpace

Mon, 05/6/24 - 11:41 am

allogeneic cells

A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach

BioSpace

Tue, 04/30/24 - 09:10 am

colorectal cancer

Annette Montandon

Vaccines, next-gen approaches target the toughest cancers: AACR

BioSpace

Fri, 04/12/24 - 11:36 am

AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit

BioSpace

Wed, 04/10/24 - 05:44 pm

accelerated approvals

7 Billion-Dollar Oncology M&As from Q1

BioSpace

Wed, 04/10/24 - 11:24 am

Bristol Myers Squibb

Mirati Therapeutics

Fusion Pharmaceuticals

Pages